Answers are grounded in this paper and cite their sources.
Umbilical cords as a source of stem cells are of increasing interest for cell therapies as they present little ethical consideration and are reported to contain immune privileged cells which may be suitable for allogeneic based therapies. Mesenchymal stem cells (MSCs) sourced from several different cord regions, including artery, vein, cord lining, and Wharton's jelly, are described in the literature. However, no one study has yet isolated and characterised MSCs from all regions of the same cord to determine the most suitable cells for cell based therapeutics.
No takes yet. Share an insight, caveat, or question.
Mennan et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: